Clinical evidence from ONTARGET: the value of an angiotensin II receptor blocker and an angiotensin-converting enzyme inhibitor

2009 ◽  
Vol 27 (Suppl 5) ◽  
pp. S23-S29 ◽  
Author(s):  
Peter Sleight
Sign in / Sign up

Export Citation Format

Share Document